ICAM-1

There are 128 papers on ICAM-1 in aging research: 30 trials and 42 observational studies in people, 33 in animals, 10 in cells, 13 reviews. The newest story, Oct 28, 2026: “Soybean carbohydrate improved blood vessel function in aged mice”.

Biomarker

128 papers study it65 more mention it25 findings

9 new papers in 30 daysSee all 193 papers on ICAM-1

“longer JT and QT intervals remained significantly associated with poorer executive function and higher serum adhesion molecules.”
Associations of Cardiac Ventricular Repolarization with Serum Adhesion Molecules and Cognitive Function in Older Adults: The MIND-China StudyJournal of Alzheimer's disease : JAD2023doi:10.3233/jad-220874
  • Human trial30
  • Humans42
  • Animals33
  • Cells10

Interventions

13

Coenzyme Q10

no changein humans2

2 studies
  1. Coenzyme Q10 showed no clear effect on ICAM-1 in humans (overweight and obese women with polycystic ovary syndrome).

    Human trialoverweight and obese women with polycystic ovary syndromecapsulesserum200 mg/day8 weeksfemalesn = 43

  2. Coenzyme Q10 showed no clear effect on ICAM-1 in humans (SMD: -0.18, 95% CI: -0.82 to 0.46, p < 0.57).

    Review

More on Coenzyme Q10

Coenzyme Q10 + selenium

downin humans1

1 study
  1. Coenzyme Q10 + selenium decreases ICAM-1 in humans (active: 0.160 μg/mL vs. placebo: 0.183 μg/mL).

    Human trial48 monthsn = 441

  2. Coenzyme Q10 + selenium decreases ICAM-1 in humans (low in selenium) (p ≤ 0.02).

    Human triallow in selenium48 monthsn = 441

More on Coenzyme Q10 + selenium

Low-frequency ultrasound

upin mice1

1 study
  1. Low-frequency ultrasound increases ICAM-1 in mice (Treatment prior to Salmonella infection).

    AnimalsTreatment prior to Salmonella infection

More on Low-frequency ultrasound

Curcumin

no changein humans1

1 study
  1. Curcumin showed no clear effect on ICAM-1 in humans (WMD: -17.05 ng/ml; 95 % CI: -80.79, 46.70).

    Review

More on Curcumin

Quercetin

no changein humans1

1 study
  1. Quercetin showed no clear effect on ICAM-1 in humans (post-myocardial infarction) (P = 0.21).

    Human trialpost-myocardial infarction500 mg/day8 weeksn = 88

More on Quercetin

Resveratrol

downin humans1

1 study
  1. Resveratrol decreases ICAM-1 in humans (WMD: -7.09 ng/ml, 95% CI: -7.45 to -6.73, p < .001).

    Review

More on Resveratrol

Tirzepatide

downin humans1

1 study
  1. Tirzepatide decreases ICAM-1 in humans (versus placebo and dulaglutide).

    Human trialversus placebo and dulaglutideonce-weekly15 mg26 weeks

More on Tirzepatide

Rapamycin

upin human cells1

1 study
  1. Rapamycin increases ICAM-1 in human cells.

    Cells

More on Rapamycin

Resistance training

downin humans1

1 study
  1. Resistance training decreases ICAM-1 in humans.

    Human trialsix monthsn = 40

More on Resistance training

Aerobic exercise

downin humans1

1 study
  1. Aerobic exercise decreases ICAM-1 in humans.

    Human trialsix monthsn = 40

More on Aerobic exercise

High-protein diet

downin humans1

1 study
  1. High-protein diet decreases ICAM-1 in humans (change from baseline to 6 months, versus hypocaloric control) (decreased, p < 0.01).

    Human trialchange from baseline to 6 months, versus hypocaloric control≥30 g protein per meal; 1.2 g/kg/day6 monthsn = 25

More on High-protein diet

Folic acid + vitamin B12

no changein humans1

1 study
  1. Folic acid + vitamin B12 showed no clear effect on ICAM-1 in humans (hyperhomocysteinemia; compared with placebo) (+36% versus +32% with placebo; p = 0.72).

    Human trialhyperhomocysteinemia; compared with placebovitamin B12 500 μg and folic acid 400 μg daily2 years55% malesn = 522

More on Folic acid + vitamin B12

Photobiomodulation

downin humans1

1 study
  1. Photobiomodulation decreases ICAM-1 in obese women undergoing aerobic plus resistance training.

    Human trialin obese women undergoing aerobic plus resistance traininginfrared laser, wavelength 808 nm, continuous output, power 100 mW, and energy delivery 50 J16 weeksfemales

More on Photobiomodulation

Upstream

1

Mus musculus

upin mice1

1 study
  1. Mus musculus increases ICAM-1 in aged mice.

    Animalsin aged micebrain

More on Mus musculus

Associations

9

Muscle mass

downin humans1

1 study
  1. ICAM-1 is associated with muscle mass in humans.

    Humansn = 427

Handgrip strength

downin humans1

1 study
  1. ICAM-1 is associated with handgrip strength in humans.

    Humansn = 427

Sarcopenia

upin humans1OR 5.146

1 study
  1. ICAM-1 is associated with sarcopenia in humans (ICAM-1 ≥1584.41 pg/mL; multivariate-adjusted association) (Adjusted OR 5.146, 95% CI 2.624–10.091).

    HumansICAM-1 ≥1584.41 pg/mL; multivariate-adjusted associationserumn = 427

More on Sarcopenia

APOE

downin humans1

1 study
  1. APOE is associated with ICAM-1 in the APOE4+ group.

    Humansin the APOE4+ group

    Protein links to Alzheimer’s markers differ by gene variant

    Neurobiology of disease

More on APOE

JT interval

upin humans1

1 study
  1. JT interval is associated with ICAM-1 in humans (dementia-free).

    Humansdementia-freen = 1,591

More on JT interval

Physical frailty and sarcopenia

upin humans1

1 study
  1. ICAM-1 is associated with physical frailty and sarcopenia in humans.

    Humans

More on Physical frailty and sarcopenia

Sleep quality

upin humans1

1 study
  1. Sleep quality is associated with ICAM-1 in humans (African American participants only) (Spearman's ρ = 0.30, P = .03).

    HumansAfrican American participants onlycerebrospinal fluid

More on Sleep quality

Epigenetic age

upin humans1

1 study
  1. ICAM-1 is associated with epigenetic age in humans (β = 0.01, 95% CI: 0.002, 0.012).

    Humansn = 552

More on Epigenetic age

Gait speed

downin humans1

1 study
  1. ICAM-1 is associated with gait speed in humans (symptomatic peripheral artery disease).

    Humanssymptomatic peripheral artery diseasemen and womensn = 231

Latest

Dec 2025: 4Jan 2026: 5Feb 2026: 1Mar 2026: 8Apr 2026: 1May 2026: 1Jun 2026: 3Jul 2026: 2Aug 2026: 6Sep 2026: 3Oct 2026: 4Nov 2026: 644 papers in 12 months
Journal of Agricultural and Food Chemistry

Soybean carbohydrate improved blood vessel function in aged mice

In 20-month-old mice, 12 weeks of supplementation restored blood vessel relaxation controlled by the vessel lining and reduced signs of inflammation.In 20-month-old mice, 12 weeks of supplementation restored blood vessel relaxation controlled by the vessel lining and reduced signs of inflammation.

Mouse studyInterventions

See all 193 papers on ICAM-1